Subsequently, we found leptin predicted “somatic anxiety” symptoms in MDD, and leptin could be a significant and indirect mediator in the association between clinical status (MDD or FDR-MDD) and “somatic anxiety” symptoms. This evidence concerns the gene LEP and major depressive disorder.